France vs Nauru: The number of people with susceptibility test result for rifampicin
France
17
in 2021
Nauru
14
in 2021
France rank
134th
Nauru rank
136th
The number of people with susceptibility test result for rifampicin over time
- France
- Nauru
How they compare
France currently reports 17 against 14 in Nauru, a difference of 3.
That makes France's figure about 1.2 times Nauru's.
Across all 5 years both countries report, France has been ahead every year.
France ranks 134th and Nauru ranks 136th of 155 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Nauru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,801 | 0 | 1,801 | France |
| 2020s | 18.5 | 7 | 11.5 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, France or Nauru?
- France, at 17 against 14 in Nauru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between France and Nauru?
- 3, with France ahead.
- How many years of comparable data are there for France and Nauru?
- 5 years are reported by both, from 2017 to 2021.
- How do France and Nauru rank globally for the number of people with susceptibility test result for rifampicin?
- France ranks 134th and Nauru ranks 136th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.